CD44 and breast cancer: Cancer cells from TNBC often display a profile of cell surface markers that are similar to that of breast cancer stem cell (BCSC), characterized by the phenotype CD44+/CD24− in which CD44 is expressed at high levels but levels of CD24 are low or undetectable (Yang et al., 2016; Honeth et al., 2008).